Sarcopenia (group A) | Sarcopenia+abdominal obesity (group B) | No sarcopenia (group C) | Significant difference between group | |
Patients n | 96 | 341 | 68 | |
Men | ||||
Muscle strength/ASM Nm·kg−1 | 4.2 (3.4–5.4) | 4.7 (4.0–5.45) | 5.2 (4.3–6.0) | A–BC, B–C |
Peak workload/ASM W·kg−1 | 3.2 (2.3–3.8) | 3.2 (2.6–4.1) | 3.6 (3.2–4.6) | AB–C |
V′O2peak/ASM mL·kg−1 | 47.6 (40.2–53.8) | 49.4 (41.9–60.4) | 55.0 (49.3–60.7) | AB–C |
CET/ASM s·kg−1 | 9.9 (7.2–12.1) | 11.5 (8.4–16.1) | 13.5 (10.6–20.8) | A–BC |
Women | ||||
Muscle strength/ASM Nm·kg−1 | 4.5 (3.9–5.1) | 5.0 (4.4–5.7) | 4.7 (3.7–5.7) | A–B |
Peak workload/ASM W·kg−1 | 4.0 (3.1–5.3) | 4.1 (3.3–4.9) | 4.4 (3.8–4.9) | ns |
V′O2peak/ASM mL·kg−1 | 60.3 (51.7–70.7) | 65.7 (56.7–73.8) | 73.1 (57.2–74.9) | ns |
CET/ASM s·kg−1 | 17.8 (12.4–23.2) | 16.4 (11.9–23.2) | 14.1 (10.1–27.2) | ns |
Data are presented as median (interquartile range), unless otherwise stated. Comparison of significant physical functioning measures expressed per kilogram appendicular skeletal muscle (ASM) across body composition phenotypes. V′O2peak: peak oxygen uptake; CET: cycle endurance time; ns: nonsignificant.